TY - JOUR
T1 - Patent foramen ovale and long-term risk of ischaemic stroke after surgery
AU - Friedrich, Sabine
AU - Ng, Pauline Y.
AU - Platzbecker, Katharina
AU - Burns, Sara M.
AU - Banner-Goodspeed, Valerie
AU - Weimar, Christian
AU - Subramaniam, Balachundhar
AU - Houle, Timothy T.
AU - Bhatt, Deepak L.
AU - Eikermann, Matthias
N1 - Funding Information:
This work was supported by Buzen, Boston, MA, USA.
Publisher Copyright:
© 2017 The Author.
PY - 2019/3/14
Y1 - 2019/3/14
N2 - Aims Pre-operatively diagnosed patent foramen ovale (PFO) is associated with an increased risk of ischaemic stroke within 30 days after surgery. This study aimed to assess the PFO-attributable ischaemic stroke risk beyond the perioperative period. Methods and results This observational study of adult patients without history of stroke undergoing non-cardiac surgery with general anaesthesia examined the association of PFO with ischaemic stroke 1 and 2 years after surgery using multivariable logistic regression. Of the 144 563 patients included, a total of 1642 (1.1%) and 2376 (1.6%) ischaemic strokes occurred within 1 and 2 years after surgery, 54 (4.7%) and 76 (6.6%) among patients with PFO, and 1588 (1.1%) and 2300 (1.6%) among patients without PFO, respectively. The odds of ischaemic stroke within 1 and 2 years after surgery were increased in patients with PFO: adjusted odds ratio (aOR) 2.01, 95% confidence interval (CI) 1.51-2.69; P < 0.001 and aOR 2.10, 95% CI 1.64-2.68; P < 0.001, respectively. Among patients who underwent contrast transoesophageal echocardiography, the frequency of PFO was 27%, and the increased stroke risk in patients with PFO was robust (aOR 3.80, 95% CI 1.76-8.23; P = 0.001 for year 1). The PFO-attributable risk was mitigated by post-operative prescription of combination antithrombotic therapy (odds ratio 0.41, 95% CI 0.22-0.75; P for interaction = 0.004). Conclusion Patients with PFO are vulnerable to ischaemic stroke for an extended period of time after surgery. Physicians should consider implementing PFO screening protocols in patients scheduled for major non-cardiac surgery.
AB - Aims Pre-operatively diagnosed patent foramen ovale (PFO) is associated with an increased risk of ischaemic stroke within 30 days after surgery. This study aimed to assess the PFO-attributable ischaemic stroke risk beyond the perioperative period. Methods and results This observational study of adult patients without history of stroke undergoing non-cardiac surgery with general anaesthesia examined the association of PFO with ischaemic stroke 1 and 2 years after surgery using multivariable logistic regression. Of the 144 563 patients included, a total of 1642 (1.1%) and 2376 (1.6%) ischaemic strokes occurred within 1 and 2 years after surgery, 54 (4.7%) and 76 (6.6%) among patients with PFO, and 1588 (1.1%) and 2300 (1.6%) among patients without PFO, respectively. The odds of ischaemic stroke within 1 and 2 years after surgery were increased in patients with PFO: adjusted odds ratio (aOR) 2.01, 95% confidence interval (CI) 1.51-2.69; P < 0.001 and aOR 2.10, 95% CI 1.64-2.68; P < 0.001, respectively. Among patients who underwent contrast transoesophageal echocardiography, the frequency of PFO was 27%, and the increased stroke risk in patients with PFO was robust (aOR 3.80, 95% CI 1.76-8.23; P = 0.001 for year 1). The PFO-attributable risk was mitigated by post-operative prescription of combination antithrombotic therapy (odds ratio 0.41, 95% CI 0.22-0.75; P for interaction = 0.004). Conclusion Patients with PFO are vulnerable to ischaemic stroke for an extended period of time after surgery. Physicians should consider implementing PFO screening protocols in patients scheduled for major non-cardiac surgery.
KW - Antithrombotic agents
KW - Paradoxical embolism
KW - Patent foramen ovale
KW - Stroke
KW - Surgery
UR - http://www.scopus.com/inward/record.url?scp=85055870647&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055870647&partnerID=8YFLogxK
U2 - 10.1093/eurheartj/ehy402
DO - 10.1093/eurheartj/ehy402
M3 - Article
C2 - 30020431
AN - SCOPUS:85055870647
SN - 0195-668X
VL - 40
SP - 914
EP - 924
JO - European Heart Journal
JF - European Heart Journal
IS - 11
ER -